I think management are playing it cool, especially by stating that the 2nd half is typically stronger and that they are on track for guidance. Reading my tea leaves, i think they will smash the guidance in 2nd half and look to surpise the market.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025